- Complete Information on Alzheimer disease with Treatment and Prevention By : Juliet Cohen
Alzheimer disease is the one of the most average cause of dementia. For Alzheimer disease there is currently no cure. - Ayurveda and Alzheimer's Disease Treatment By : Dev_Sri
Alzheimer's disease is a progressive degenerative brain disease. Gradual memory loss, poor cognitive skills, dementia and personality problems are the main symptoms associated with Alzheimer's disease. Though there is not a complete cure for Alzheimer's, Ayurveda has the knowledge to treat an Alzheimer's patient. - Detailed Information on Embolism By : Juliet Cohen
PE may arise from deep vein thrombosis throughout the body. Fatal PE is often a result of thrombus emanating from the sub-axillary or veins (deep veins in the arm or shoulder) or in the veins of the pelvis. Several factors can make someone more likely to develop a blood clot, which can eventually break loose and travel into the lungs. Operations are a major cause of blood clot problems, including the replacement operations major joints such as the hip and knee. - Detailed Information on Alcoholism By : Juliet Cohen
Alcohol in the severity of the problems range from mild to life-threatening and affect the individual, the person \ 's family, and society in many ways unfavourable. Alcoholism is characterized by a concern for alcohol and disorder control over alcohol consumption. Alcoholism is a chronic, often progressive disease. Alcohol may also refer to a concern for the direction of coercion or the use of alcohol and / or impairment of the ability to recognize the negative effects of excessive alcohol consumption. - Facts About Alzheimer's Diseases By : Juliet Cohen
Alzheimer's disease is a neurodegenerative disease. It is found in people over age 65. AD is also considered a tauopathy due to abnormal aggregation of the tau protein, a microtubule-associated protein expressed in neurons that normally acts to stabilize microtubules in the cell cytoskeleton. - Vitiligo - Causes, Symptoms and Treatment By : Juliet Cohen
Vitiligo is a specific type of leukoderma and it is characterized by depigmentation of the epidermis. It affects at least one in every hundred people in countries throughout the world including the UK. - Study Shows Cats Can Succumb To Feline Alzheimer's Disease By : Alzheimers News
Ageing cats can develop a feline form of Alzheimer's disease, a new study reveals. Scientists at the Universities of Edinburgh, St Andrews, Bristol and California have identified a key protein which can build up in the nerve cells of a cat's brain and cause mental deterioration. - Copy Cat Protein Links Feline And Human Alzheimer's By : Alzheimers News
Researchers at Edinburgh, St Andrew's and Bristol Universities in the UK have found that a protein linked to Alzheimer's in humans also builds up in the brain cells of aged cats who suffer from the same symptoms. - Scientists Develop A New Way To Target Alzheimer's Disease By : Alzheimers News
The pathological embrace between two proteins plays a key role in the development of Alzheimer's disease by triggering the formation of neuron-killing plaques of amyloid beta protein. Now a group of scientists at NYU School of Medicine have devised a way to reduce amyloid beta deposition by interfering with the deadly embrace of these proteins. - Complaints About Memory Are Associated With Alzheimer-Related Brain Damage By : Alzheimers News
Researchers at Rush University Medical Center found that having complaints about memory problems is associated with changes in the brain related to Alzheimer's disease. They reported their findings in the November 2006 issue of Neurology. - The Alliance For Aging Research Unveils New Resource For Family Caregivers Of Alzheimer's Patients By : Alzheimers News
The Alliance for Aging Research has partnered with the National Family Caregivers Association to develop a new resource to educate family caregivers on how to care for themselves while caring for a loved one with Alzheimer's - Case Western Reserve University Study Examines Changing Roles, Emotions In Caregiving By : Dementia News
The early stages when a spouse or an adult child becomes a caregiver for someone with Alzheimer's disease or another type of progressive dementia is fraught with a tug-of-war of emotions from resentment to protectiveness, according to a new study from the Mandel School of Applied Social Sciences at Case Western Reserve University. - Alzheimer's Patient Volunteers For First Scan By : Dementia News
The University of Manchester's Wolfson Molecular Imaging Centre will carry out its first positron emission tomography (PET) brain scan on a patient volunteer this Friday (24 November 2006) at 10.00. - More Insight Into Alzheimer's Disease With Stanford Discovery Of Possible Cause By : Dementia News
A peacekeeper in the body's defenses against infection may hold the key to understanding - and eventually treating - Alzheimer's disease. Researchers at the Stanford University School of Medicine discovered that when a molecule responsible for dialing down the immune system malfunctions in the brain cells of mice, the rodents develop symptoms of the degenerative brain disease. - Novel Program Enhances Dementia Caregivers' Quality Of Life By : Dementia News
A multifaceted, personalized intervention can significantly improve the quality of life for caregivers of people with dementia, new research published in Annals of Internal Medicine has found. - Dementia Care Intervention Eases Burden For Families By : Dementia News
Intervention sessions, individually tailored to help people caring for family members with dementia, show promise in reducing rates of clinical depression, according to a multi-site study co-authored by a University of Alabama researcher. - Study On Neuronal Circuits May Help Explain Memory And Cognitive Decline In Alzheimer's Disease By : Alzheimers News
A discovery on how neural circuitry develops to aid proper cerebral cortex activity may help explain the memory and cognitive decline seen in Alzheimer's disease patients - a discovery that could point toward potential treatments, according to UC Irvine scientists. - Yeast Model Shows Promise As Alzheimer's Test By : Dementia News
A century ago this month, German psychiatrist Alois Alzheimer formally described characteristics of the neurodegenerative disease which ultimately came to bear his name. While international efforts to learn about Alzheimer's disease and develop treatments have progressed significantly in recent years, a cure remains an elusive goal. - Occupational Therapy Improves Quality Of Life For Dementia Patients And Their Carers, UK By : Dementia News
Occupational therapy can help to improve the ability of people with dementia to perform daily activities and can also reduce the pressure on their caregivers, says a BMJ study published today. - Experts Support The Continual Prescribing Of Ebixa (memantine) For Treating The UK's Moderate To Sev By : Dementia News
The National Institute for Health and Clinical Excellence (NICE) has today jointly published its guidance on the use of drugs to treat Alzheimer's disease (AD) and the clinical guideline on the management of all types of dementia, including AD, jointly with the Social Care Institute for Excellence. - Prana Biotechnology Raises Approximately 6 Million US Dollars To Fully Fund Its Phase IIa Clinical T By : Dementia News
Prana Biotechnology Limited (Nasdaq: PRAN; ASX: PBT), today announced it has entered into agreements to raise approximately 6.0 million US Dollars (7.8 million A Dollars) from new institutional investors in Australia, existing institutional investors in the United States and a founding member of the Company - NICE SCIE Guideline To Improve Care Of People With Dementia, UK By : Dementia News
The National Institute for Health and Clinical Excellence (NICE) and the Social Care Institute for Excellence (SCIE) today (22 November) issue joint guidance on the treatment and care of people with dementia in health and social care. - The Role Of Metals In Alzheimer's Disease Explored By : Dementia News
Alzheimer's disease (AD) is a devastating condition and its causes are still largely unknown. Various metals have been implicated as possible contributors to the development of AD. In a special double issue of the Journal of Alzheimer's Disease published in November 2006, guest editors Andrei C. Miu and Oana Benga have brought together 14 insightful articles that explore the roles that metals play in the biochemistry and physiology of AD. - Counseling Caregivers Helps Alzheimer's Patients Stay Home Longer By : Dementia News
Counseling leading to improved well-being for the spouse caregivers of Alzheimer's Disease patients can result in a substantial delay in nursing home placement for their loved ones with AD, according to researchers from the University of South Florida, New York University School of Medicine and the University of Alabama at Birmingham. - Alzheimer's Foundation Of America Sets Standard Of Excellence For Dementia Settings By : Alzheimers News
As part of its ongoing efforts to raise the bar on dementia care, the Alzheimer's Foundation of America (AFA) has developed a nationwide standard of excellence for settings that provide care to individuals with Alzheimer's disease or related dementias. - Statin Drugs Gain Traction as Potential Treatment for Alzheimer’s Disease By : Health News
Statins, the widely used cholesterol drugs with a global market over $25 billion, are gaining wide attention as a potential new way of treating Alzheimer’s disease (AD) according to recent reports. The Wall Street Journal noted the promise of statins for Alzheimer’s disease and highlighted the pressing need for new and effective treatments for this major disease (October 17, 2006 Several Drugs Show Promise For Alzheimer's). - Medivation Provides Clinical Development Update For Its Three Programs By : Dementia News
Medivation, Inc. (Amex: MDV) today announced updated clinical development plans and milestones for its three programs in Alzheimer's disease, Huntington's disease and hormone-refractory prostate cancer. - Lower Dementia Risk And Higher Level Of Certain Fatty Acid Linked By : Dementia News
Individuals who have higher levels of a fatty acid known as docosahexaenoic acid (DHA) in their blood may have a significantly lower risk of developing dementia and Alzheimer's disease, according to a report in the November issue of Archives of Neurology, one of the JAMA/Archives journals. - Counseling Alzheimer's Caregivers Postpones The Nursing Home By : Dementia News
A program of individual and family counseling sessions and ongoing support for people who are caring for a husband or wife with Alzheimer's disease has a major impact on how long they can keep their spouses at home with them. Alzheimer's disease and other dementias are a major reason why people are placed in nursing homes in the United States. - Potential Underlying Cause For Dementia After Cancer Treatment Suggested By Study By : Dementia News
Researchers at Wake Forest University School of Medicine have identified changes in brain chemistry that may be associated with the dementia that many cancer patients develop after whole-brain radiation treatment. - Alzheimer's Disease Diagnosed 100 Years Ago By : Dementia News
One hundred years after the first diagnosis of Alzheimer's disease (AD) November 3, 1906, researchers at the Yerkes National Primate Research Center, Emory University, are focusing on neuroscience, immunology and vaccine research to better understand how AD develops and progresses as well as to advance the treatment and prevention of this progressive brain disorder. - New Alzheimer's Drug Shows Promise In Clinical Trial By : Dementia News
The only drugs currently available for Alzheimer's patients are those that alleviate symptoms, but a team of scientists led by Paul Aisen, MD, director of the Memory Disorders program at Georgetown University Medical Center, is testing a new class of drugs that actually target the molecule believed to cause the disease. - Core Principles Of Care For Alzheimer's Disease Have Remained The Same Over The Past 100 Years By : Dementia News
While the treatment of Alzheimer's disease has advanced over the past 100 years, the core principles of care have remained the same, according to a the authors of a Viewpoint in this week's issue of The Lancet. The publication coincides with the anniversary of the first presentation of the disease by psychiatrist and pathologist Alois Alzheimer in Tubingen, Germany, on November 3, 1906. - More Sensitive Tool For Detecting Dementia By : Dementia News
A screening tool for dementia developed by Saint Louis University geriatricians appears to work better in identifying mild cognitive problems in the elderly than the commonly used Mini Mental Status Examination, according to a new study - Alzheimer's Disease Discovered 100 Years Ago, November 4th By : Dementia News
According to the Alzheimer's Association, Alzheimer's disease was discovered 100 years ago on Saturday, November 4, 2006. Currently 4.5 million people in America have Alzheimer's and that figure is expected to grow to as many as 16 million by 2050. - Massage May Help Dementia Patients With Agitation By : Dementia News
Massage could offer a drug-free way to treat agitation and depression among dementia patients, but there are still too few studies about the practice to know for sure, according to a review of recent research. - Alzheimer's Foundation Of America Marks National Alzheimer's Disease Awareness Month By : Dementia News
The Alzheimer's Foundation of America (AFA) is marking National Alzheimer's Disease Awareness Month this November with three major national initiatives aimed at raising awareness of this devastating brain disorder from educational and emotional vantage points. - Dementia On The Rise In Aging Populations By : Dementia News
Life expectancy continues to rise in most countries around the world, and in industrialized nations it is not uncommon for people to live well into their 90s. One consequence is that dementia will become much more common, as a new study reported by Fiona Matthews ,Carol Brayne and the Medical Research Council Cognitive Function and Ageing Study Investigators published in the open-access international medical journal PLoS Medicine suggests. - Case Western Reserve University Hosts 100th Anniversary Of Alzheimer's Disease Conference By : Conferences News
The year 2006 marks the 100th anniversary of the first case of Alzheimer's disease to the medical world. Currently there are 4.5 million Americans (18 million worldwide) with the disease, and these figures are estimated to double by the year 2025. The cost to societies is overwhelming. Dementia is currently one of the most costly and devastating diseases, both to persons with dementia as well as to their families. - Blood Test May Detect Alzheimer's Disease Long Before Symptoms Appear By : Dementia News
A new blood test is being developed which detects two types of proteins only present in people with Alzheimer's disease, say scientists from the Institute of Psychiatry at King's College London, UK. The test can identify Alzheimer's disease long before the patient starts having the symptoms - before he/she even knows he/she has got Alzheimer's. - Scientists Have Created A New Chemical Compound That Could Lead To A Drug Treatment For Alzheimer's By : Dementia News
Scientists at the University of Liverpool have created a new chemical compound that could be developed into a drug treatment for Alzheimer's disease. - Novel Three-Dimensional Imaging Technique Used By Researchers By : Dementia News
FINDINGS: Using an innovative three-dimensional imaging technique, a team of UCLA researchers have tracked how Alzheimer's disease spreads through the hippocampus. - Hope Remains For Alzheimer's Sufferers By : Dementia News
The National Institute of Clinical Excellence (NICE), who last week rejected appeals to allow patients with mild Alzheimer's to receive the life-changing medication donepezil (Aricept®), will hopefully re-appraise their decision in 3 years time, according to neurologist Professor Robert Kerwin in an article published in the November issue of the medical journal Future Neurology. - Naturally Occurring Enzyme Can Break Down Key Part Of Alzheimer's Plaques By : Dementia News
Scientists have identified a naturally occurring enzyme that can break down a key component of the brain plaques characteristic of Alzheimer's disease. The finding may provide researchers with new opportunities to understand what goes wrong in the brains of Alzheimer's patients and could one day help them seek new therapies. - Mental Function In Patients With Alzheimer's Enhanced By Computer-Based "Games" By : Dementia News
Computer-based tasks aimed at increasing mental activity and enhancing mental function can improve cognition in patients with Alzheimer's disease, serving as an effective addition to medications commonly used to treat the disease. - $52 Million To Lead Alzheimer's Disease Study Received By UCSD By : Dementia News
Leon Thal, Director of the Shiley-Marcos Alzheimer's Disease Research Center at UCSD, heads 70-site consortium funded by National Institutes of Health - Latest Buzz: Marijuana May Slow Progression Of Alzheimer's Disease By : Dementia News
New evidence in rats suggests that marijuana may contain compounds that slow the memory loss associated with Alzheimer's disease. - New Alzheimer's Clinical Trials To Be Undertaken By NIA Nationwide Consortium, US By : Dementia News
The Alzheimer's Disease Cooperative Study (ADCS), a federally-established consortium conducting clinical trials on Alzheimer's disease (AD), will receive $52 million over six years to conduct several new trials, the National Institutes of Health (NIH) has announced. The award is a cooperative agreement between the NIH's National Institute on Aging (NIA) and the University of California, San Diego (UCSD), which coordinates the consortium of nearly 70 sites in the United States and Canada. - DURECT Provides An Update To The Memryte(TM) Program Under Development By Voyager Pharmaceutical By : Dementia News
DURECT Corporation (Nasdaq: DRRX) announced today that Voyager Pharmaceutical has informed DURECT that Voyager is ending its Phase III clinical trials for Memryte(TM) for the treatment of Alzheimer's Disease in order to get an earlier look at potential efficacy from over 600 accrued patients. - Memory Screening Survey Shows Americans Are Concerned About Memory Loss, Though Few Share Concerns By : Health News
A MetLife Mature Market Institute study of people who attended voluntary memory screening during National Memory Screening Day sponsored by the Alzheimer’s Foundation of America (AFA) shows 73% have memory concerns, though many may be reluctant to discuss them with others, even their physician. - Martek's DHA Selected For NIH-Funded Alzheimer's Study By : Dementia News
Martek Biosciences (Nasdaq: MATK) announced today that its vegetarian source of DHA (docosahexaenoic acid) omega-3 derived from microalgae was the only DHA source selected for use in an upcoming multi-million dollar National Institutes of Health (NIH)-funded study on the effects of DHA in slowing the progression of Alzheimer's disease. - Little Benefit From Antipsychotics In Alzheimer's, Suggests USC-led Study By : Dementia News
Most Alzheimer's patients prescribed antipsychotic drugs for delusions, agitation or aggression do no better than those who take a placebo because so many discontinue the drugs due to significant side effects, according to a major new nationwide study led by Lon Schneider, professor of psychiatry, neurology and gerontology at the Keck School of Medicine of the University of Southern California (USC). - U.S. Food And Drug Administration Approves ARICEPT(R) For Treatment Of Severe Alzheimer's Disease By : Dementia News
Eisai and Pfizer Inc announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for ARICEPT(R) (donepezil HCl tablets) for treatment of severe Alzheimer's disease (AD). - Memory Pharmaceuticals Provides Update On Phase 2a Trial Of MEM 3454 In Alzheimer's Disease By : Dementia News
Memory Pharmaceuticals Corp. (Nasdaq: MEMY) today announced an update on the investigational new drug application (IND) filed in September 2006 with the U.S. Food and Drug Administration (FDA) for MEM 3454. The FDA has advised the Company that in order to fully review the toxicology reports that were submitted with the IND. - Study Suggests Little Benefit From Antipsychotics In Alzheimer's By : Dementia News
Most Alzheimer's patients prescribed antipsychotic drugs for delusions, agitation or aggression do no better than those who take a placebo because so many discontinue the drugs due to significant side effects, according to a major new nationwide study led by Lon Schneider, professor of psychiatry, neurology and gerontology at the Keck School of Medicine of the University of Southern California (USC). - NICE Announces Alzheimer's Disease Drug Appeal Outcome And NHS Guideline To Support Patients By : Dementia News
NICE has announced that the appeals lodged by stakeholders against draft guidance on the use of drugs to treat Alzheimer's Disease have not been upheld. NICE will recommend to the NHS in November that donepezil, galantamine and rivastigmine should only be considered as options in the treatment of people with moderate Alzheimer's disease. Memantine is only recommended as part of clinical studies for people with moderately-severe to severe Alzheimer's disease. - Reduced Risk Of Alzheimer's Disease Associated With Mediterranean Diet By : Dementia News
Eating a Mediterranean diet, which emphasizes fruits, vegetables and olive oil and includes little red meat, is associated with a lower risk for Alzheimer's disease, according to an article posted online that will appear in the December 2006 print issue of Archives of Neurology, one of the JAMA/Archives journals. - Antipsychotic Drugs Have Too Many Side Effects For Alzheimer's Patients By : Dementia News
Antipsychotic drugs, such as Zyprexa, Seroquel and Risperdal, have side effects which are greater than their benefits for Alzheimer's patients, say researchers from the USA. These drugs are regularly prescribed to treat psychosis and aggression in patients with Alzheimer's disease. - Omega-3 Fatty Acids May Slow Down Early Alzheimer's In Some Cases By : Dementia News
Omega-3 fatty acid supplements may slow cognitive decline in some patients with very mild Alzheimer's disease, according to new findings from Karolinska Institutet (KI) in Sweden. However, the positive affect of Omega-3 do not appear in cases with more advanced Alzheimer's. This is the first clinical trial ever made in the field and the result is published in the October issue of Archives of Neurology, one of the JAMA/Archives journals. - ABPI Condemns NICE'S Decision On Alzheimer's Medicines, UK By : Dementia News
The decision by the National Institute for Clinical and Health Excellence (NICE) to reject appeals against its decision regarding the use of anti-dementia medicines in the treatment of Alzheimer's disease has been condemned by the Association of the British Pharmaceutical Industry (ABPI). - NICE Appeal Leaves Inequity Of Access To A Licensed NHS Treatment For UK's 309,000 AdvancedAlzheimer By : Dementia News
Lundbeck is disappointed that the Appeal Committee for the National Institute for Health and Clinical Excellence (NICE) has decided not to recommend obligatory NHS funding for the routine prescription of Ebixa (memantine) in England and Wales for the treatment of moderately severe to severe Alzheimer's disease (AD)2. However, the Appeal Committee did uphold Lundbeck's Appeal to amend their statement to acknowledge that they had not reviewed the moderate extension to Ebixa's indication3. - Mediterranean Diet Lowers Alzheimer's Risk By : Dementia News
If you follow a Mediterranean diet your chances of developing Alzheimer's disease could be 68% lower than people who don't, say researchers from Columbia University Medical Center, New York. - Marijuana's Active Ingredient May Slow Progression Of Alzheimer's Disease By : Dementia News
Scientists are reporting discovery in laboratory experiments of a previously unknown molecular mechanism in which the active ingredient in marijuana may slow the progression of Alzheimer's disease (AD). Scripps Research Institute's Kim D. Janda and colleagues used laboratory experiments to show that delta-9-tetrahydrocannabinol (THC) preserves brain levels of the key neurotransmitter acetylcholine. - Misfolded Protein Clumps Common To Dementia, Lou Gehrig's Disease, Discovered By Researchers By : Dementia News
Scientists have identified a misfolded, or incorrectly formed, protein common to two devastating neurological diseases, frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease), according to a report in the Oct. 6, 2006, issue of Science. The findings suggest that certain forms of FTD, ALS and possibly other neurological diseases might share a common pathological process. - Memory Walk® Successfully Raises Awareness and Funds to Support the Mission of the Alzheimer’s By : Health News
The Alzheimer's Association’s 14th annual Memory Walk brought out thousands of walkers whose mission was to help people with Alzheimer’s disease by raising funds to support the programs and services provided by the Association. With a total of ten walks taking place from the Berkshires and Central Massachusetts to South Shore and Greater Boston, the events exceeded the organization’s goals for walker turnout and met their fundraising goal. - Chemical Found In Curry May Help Immune System Clear Amyloid Plaques Found In Alzheimer's Disease By : Dementia News
UCLA/VA researchers found that curcumin -- a chemical found in curry and turmeric -- may help the immune system clear the brain of amyloid beta, which form the plaques found in Alzheimer's disease. - Regulatory Approval To Start PBT2 Phase IIa Clinical Trial In Alzheimer's Disease Patients By : Dementia News
Prana Biotechnology Limited (Nasdaq: PRAN; ASX: PBT), today announced that it has received regulatory approval from Sweden's Medical Products Agency (MPA) to start a Phase IIa clinical trial of its proprietary lead compound, PBT2, in patients with early Alzheimer's disease. The trial will be conducted in seven centres in Sweden. - Optics Tests For Early Alzheimer's Diagnosis Make Significant Advances By : Dementia News
Providing an update on progress and new findings on his optical tests for the early detection of Alzheimer's disease, Lee Goldstein of Brigham and Women's Hospital and Harvard Medical School will describe dramatic new developments in the technology during a plenary talk at Frontiers in Optics, the annual meeting of the Optical Society of America (OSA) in Rochester, N.Y., which takes place next week. - Drug May Delay Nursing Home Placement For Dementia Patients By : Dementia News
Publishing in the September issue of Alzheimer's Disease and Associated Disorders researchers from the University of South Florida's Louis de la Parte Florida Mental Health Institute's (FMHI) Department of Mental Health, Law and Policy and the School of Aging Studies report finding that treating dementia patients with cholinesterase inhibitors (ChE-Is) may delay placement into nursing homes and provide improved quality of life while helping preserve personal and societal resources. - Intranasal Insulin Delivered By ViaNase(TM) Improves Short-term Memory In Alzheimer's Disease Study By : Dementia News
Kurve Technology Inc, a leader in nasal drug delivery devices, today announced the delivery of insulin by the ViaNase electronic atomizer significantly improved memory in patients with Alzheimer's Disease (AD) or Amnestic Mild Cognitive Impairment (MCI). - OSA Meeting To Showcase State-Of-The-Art Discoveries: New Details About Alzheimer's Detection By : Conferences News
Frontiers in Optics 2006--the 90th Annual Meeting of the Optical Society of America (OSA)--will showcase a wide range of the latest research breakthroughs in optical science and engineering. The meeting will be held from Oct. 8-12 at the Rochester Convention Center in Rochester, N.Y., the city known as the birthplace of modern-day optics. - In Early Alzheimer's Disease Microscopic Brain Damage Detected By : Dementia News
Researchers have developed a new computer-aided analysis technique to identify early cellular damage in Alzheimer's disease (AD). The study is featured in the October issue of Radiology. - Role Of Folate And Homocysteine In Alzheimer's Disease Examined By : Dementia News
There may be a connection between dietary deficiencies and Alzheimer's disease. In a special issue of the Journal of Alzheimer's Disease published this month, ten contributions from worldwide experts in the field examine possible linkages between folate and homocysteine and Alzheimer's disease. - Low Calorie Diet May Help Prevent Alzheimer's By : Dementia News
A diet low in calories can help stop the development of Alzheimer's disease, if a study on squirrel monkeys applies to humans, say researchers from the Mount Sinai School of Medicine, New York, USA. - Alzheimer's Protein Shredded By Enzyme By : Dementia News
An enzyme found naturally in the brain snips apart the protein that forms the sludge called amyloid plaque that is one of the hallmarks of Alzheimer's disease (AD), researchers have found. They said their findings in mice suggest that the protein, called Cathepsin B (CatB), is a key part of a protective mechanism that may fail in some forms of AD. - Researchers Discover New Key Function Of An Enzyme In The Nervous System - Impact On DrugDevelopment By : Dementia News
Ever since scientists first elucidated the molecular mechanisms underlying the pathology and loss of nerve cells in Alzheimer's disease, drug companies have been working to develop drugs which will inhibit the outbreak of this severe form of dementia. - Carers Condemn Serious Gaps In Dementia Care Alzheimer's Groups Campaign For Appropriate Disease By : Dementia News
A pan-European report: ‘Who cares? The state of dementia care in Europe', published today (World Alzheimer's Day) by Alzheimer Europe, highlights serious gaps in dementia care. Dementia is a major public health problem. However, one hundred years after Alois Alzheimer first described the disease, less than half of people with Alzheimer's disease (AD) have access to healthcare support services.1 - New Dementia Care Guidelines For Use In Disaster Situations - Coalition Provides Insights By : Dementia News
A coalition* of long term care and consumer organizations, released today a new guide to providing care for persons with dementia during emergencies, such as a major disease outbreak, hurricane or fire. - Risk Of Alzheimer's Disease Reduced By Cabernet Sauvignon Red Wine By : Dementia News
A new study directed by Mount Sinai School of Medicine has found that moderate red wine consumption in a form of Cabernet Sauvignon may help reduce the incidence of Alzheimer's Disease (AD). The study entitled "Moderate Consumption of Cabernet Sauvignon Attenuates a-amyloid Neuropathology in a Mouse Model of Alzheimer's Disease" is in press, and will be published in the November 2006 issue of The FASEB Journal. - World Alzheimer's Day 2006 - Thursday 21st Sept By : Dementia News
One hundred years after Dr Alois Alzheimer first described Alzheimer's disease, the world unites to commemorate World Alzheimer's Day tomorrow, 21 September. - Roskamp Institute Marks World Alzheimer's Day By Announcing The Launch Of Major Clinical Study By : Dementia News
The Roskamp Institute of Sarasota, Florida, today announced the launch of a major clinical study to test a promising new drug application for the treatment of Alzheimer's Disease. The announcement, timed to coincide with this week's World Alzheimer's Day, marks the first time that a Florida-based research institute has conducted human clinical studies resulting from its own original Alzheimer's research. World Alzheimer's Day is this Thursday, September 21. - Restricting Calories In Non-human Primates May Prevent And Reduce Alzheimer's Disease Neuropathology By : Dementia News
A new study directed by Mount Sinai School of Medicine extends and strengthens the research that experimental dietary regimens might halt or even reverse symptoms of Alzheimer's Disease (AD). - The Ethics Of Finding Answers To Dementia - Center Policy Brief Advances Protection For Individuals By : Dementia News
Not too many years into the future, approximately 70 million Baby Boomers will be age 65 or older. Some 44 states are projected to have Florida-like population demographics. Nearly one-third of this population will have significant dementia. Healthcare expenditures, already four times higher for a 65-year-old than a 40-year-old, will skyrocket by 25 percent. - New Insights Into The Cause Of Alzheimer's Disease - Possible Starting Points For Developing By : Dementia News
Scientists are gaining ever more insight into the causative mechanisms involved in Alzheimer's disease. Thus, they can identify possible attack points for a targeted, causative treatment of this severe brain disorder which affects millions of people worldwide, as reported at the international conference “Neurodegenerative Diseases: Molecular Mechanisms in a Functional Genomics Framework” in the Max Delbrück Communications Center (MDC.C) in Berlin-Buch (Germany).
|
